GEMINEYECO is an early-stage biotechnology venture decoding the biology of women's health and disease — and translating what it finds into the treatments women have gone without.
We study women's health where it actually begins — in human tissue, and in the matrix that holds it together.
GEMINEYECO is an early-stage biotechnology venture built around a single conviction: that women's health has been under-researched for far too long, and that the conditions women live with deserve treatments designed for the biology behind them. We are an interdisciplinary team of scientists working to uncover the biological mechanisms that underlie women's health and disease — and to translate that understanding into better options for treatment.
Our stated starting point is endometriosis, a condition that affects millions and has gone without a cure. But our ambition is larger than any single diagnosis. We are building a way of doing therapeutic discovery — grounded in human tissue rather than distant proxies — that we believe can reshape how treatments for women are found. The company is backed by external investors who share that long view, and we share our progress as the science advances.
Most drug discovery begins far from the human body — in cell lines and animal models that only loosely resemble the disease they stand in for. GEMINEYECO begins somewhere else entirely: in human tissue itself, and in the matrix that surrounds and shapes it.
We pay particular attention to the extracellular matrix — the structural scaffold around every cell that governs how tissue behaves in health and in disease. By working at the level of the tissue niche, in both the data we collect and the disease models we build, we change what therapeutic discovery is able to see. The result is biology that mirrors what is actually happening inside the body, rather than an approximation of it.
Three connected objectives, all powered by one tissue-level method — turning a richer view of disease into therapies aimed where they matter.
Conditions in women's health are too often treated as one disease when they are many. Using tissue-level data, we stratify these conditions and surface new health insights — distinguishing between subtypes that conventional methods group together — so treatment can finally be matched to the disease a person actually has.
Get involvedTo find treatments that work in people, you need models that behave like people. We build physiological assays of the tissue niche — first of their kind — engineered to mimic human disease far more closely than the models discovery has long relied on. These living systems let us test hypotheses against biology that reflects the real thing.
Get involvedA treatment is only as good as the target it aims at. By studying disease in human tissue and its matrix, we work to identify the biological targets that genuinely drive it — not the bystanders that merely accompany it. Those validated targets become the foundation for therapies directed exactly where they are needed.
Get involvedGEMINEYECO brings together expertise from across biology, engineering, and medicine — a single interdisciplinary team pointed squarely at the mechanisms of women's health and disease, and at translating them into treatments.
Central to our method is an unusual and powerful biological sample: menstrual fluid. For the conditions we study, it offers living, tissue-level material that is specific to the very biology in question — and it has been overlooked by conventional research for far too long.
From this material we draw the data and build the disease models that make tissue-level discovery possible. It is, quite literally, the source of our understanding — a window onto women's health biology that traditional sampling simply doesn't open.
Our work is powered in part by people who choose to take part. Through our donation program, we invite people to donate menstrual fluid in support of the research — contributing directly to the search for treatments in women's health.
Every consented sample helps us see disease more clearly and bring better options closer. There is no donation too small to matter, and no curiosity too early to act on. If you'd like to take part, we'd love to hear from you.
Join the donation programBecause our data and our disease models come from human tissue and a human-derived sample, discovery is grounded in the real thing from the very start — a clear departure from the proxies that traditional drug development leans on.
Whether you're a scientist, a potential collaborator, an investor, a journalist, or someone who wants to support the work by donating to the research — we'd like to hear from you. Send a note and a member of the GEMINEYECO team will follow up.
Your email client should now be open with your note to hello@gemineyeco.com. If it didn't open, email us directly and we'll be in touch shortly.